A new study designed to investigate how a patient’s COVID-19 ICU hospitalization affects the mental health of family members is currently under way at South Shore Hospital.

South Shore Hospital’s Cardiac Catheterization Lab is the first in New England to adopt revolutionary diagnostic imaging technology that provides clinicians results in seconds while vastly improving the patient experience. The CathWorks FFRangio® System is a computer-based technology that uses x...

In May 2021, South Shore Hospital, part of South Shore Health, partnered with Boston Children’s Hospital on a new COVID-19 clinical trial. Patients admitted to the intensive care unit with severe COVID-19 pneumonia who require mechanical ventilation are invited to participate in this study. The...

South Shore Hospital has been recognized for its responsible use of coronary stent and angioplasty procedures in a report by The Lown Institute, an independent think tank based in Brookline, Mass. It is listed as having one of the lowest rates of overuse of coronary stent or balloon angioplasty...

What started in 2006 as a program with one nurse and 30 machines has grown to include coverage seven days a week using medical equipment that has the capacity to remotely monitor up to 175 patients.

The growing number of coronavirus cases across Massachusetts has led to new guidance from the state, which requires us to postpone select inpatient surgeries to keep beds open in the event they are needed for critically ill patients.

The purpose of the project is to create and maintain a national resource documenting and studying neurological complications of coronavirus disease, the illness caused by infection with the SARS-CoV-2 novel coronavirus.

One year after being chosen as the pilot site for a one-of-its-kind study, South Shore Hospital, part of South Shore Health, has seen a nearly 4-percent decrease in its first time cesarean section rate while continuing to improve communication, patient experience and outcomes during childbirth.

With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.

Made possible by a nearly $142,000 grant from the Dunkin’ Joy in Childhood Foundation, these modified rooms are calming, controlled spaces aimed at reducing stress, agitation, and anxiety for patients, particularly those who are neurodivergent or on the autism spectrum.